D.A. Davidson & CO. Has $17.72 Million Stock Position in UnitedHealth Group Incorporated $UNH

D.A. Davidson & CO. increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 33.7% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 56,801 shares of the healthcare conglomerate’s stock after buying an additional 14,315 shares during the quarter. D.A. Davidson & CO.’s holdings in UnitedHealth Group were worth $17,720,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Bayforest Capital Ltd raised its stake in shares of UnitedHealth Group by 685.7% in the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd raised its stake in shares of UnitedHealth Group by 416.7% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock worth $32,000 after purchasing an additional 50 shares during the last quarter. Kentucky Trust Co raised its stake in shares of UnitedHealth Group by 53.8% in the second quarter. Kentucky Trust Co now owns 143 shares of the healthcare conglomerate’s stock worth $45,000 after purchasing an additional 50 shares during the last quarter. O Brien Wealth Partners LLC raised its stake in shares of UnitedHealth Group by 74.0% in the first quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate’s stock worth $46,000 after purchasing an additional 37 shares during the last quarter. Finally, Cloud Capital Management LLC bought a new position in shares of UnitedHealth Group in the first quarter valued at approximately $53,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Down 1.1%

NYSE:UNH opened at $361.29 on Thursday. The company has a market cap of $327.21 billion, a P/E ratio of 15.65, a P/E/G ratio of 2.36 and a beta of 0.47. The stock’s fifty day moving average price is $335.48 and its two-hundred day moving average price is $341.42. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company’s revenue was up 12.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were given a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio (DPR) is 38.30%.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the company. UBS Group reaffirmed a “buy” rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Bank of America upped their target price on UnitedHealth Group from $350.00 to $390.00 and gave the company a “neutral” rating in a report on Wednesday, October 8th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $440.00 target price on shares of UnitedHealth Group in a report on Tuesday, August 26th. Mizuho increased their price objective on UnitedHealth Group from $300.00 to $430.00 and gave the company an “outperform” rating in a report on Thursday, October 9th. Finally, Sanford C. Bernstein increased their price objective on UnitedHealth Group from $379.00 to $433.00 and gave the company an “outperform” rating in a report on Wednesday, October 8th. Eighteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $385.13.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.